Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia

Standard

Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia. / Gallinat, Jürgen; McMahon, Kibby; Kühn, Simone; Schubert, Florian; Schaefer, Martin.

in: SCHIZOPHRENIA BULL, Jahrgang 42, Nr. 2, 2016, S. 425-433.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{92399b2c5c034afab3300b5e7529ea7c,
title = "Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia",
abstract = "BACKGROUND: There has been growing support for dysfunctions of the excitatory glutamatergic system and its implications for the psychophysiology of schizophrenia. However, previous studies reported mixed results regarding glutamate concentrations in schizophrenia with varying deviations across brain regions.METHODS: We used an optimized proton magnetic resonance spectroscopy procedure to measure absolute glutamate concentrations in the left hippocampal region and the anterior cingulate cortex (ACC) in 29 medicated patients with schizophrenia and in 29 control participants without mental disorder.RESULTS: The glutamate concentrations were significantly lower in the ACC but higher in the hippocampus of patients compared to controls. ACC and hippocampal glutamate concentrations correlated positively in patients but not in controls. ACC glutamate was weakly associated with Clinical Global Impression score and duration of illness in patients.CONCLUSION: Glutamate concentrations in schizophrenia deviate from controls and show associations with disease severity. A higher concentration of hippocampal glutamate in schizophrenia compared to controls is shown. The association between ACC and hippocampus glutamate concentrations in patients with schizophrenia suggests an abnormal coupling of excitatory systems compared to controls as predicted by previous glutamate models of schizophrenia.",
author = "J{\"u}rgen Gallinat and Kibby McMahon and Simone K{\"u}hn and Florian Schubert and Martin Schaefer",
note = "{\textcopyright} The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.",
year = "2016",
doi = "10.1093/schbul/sbv124",
language = "English",
volume = "42",
pages = "425--433",
journal = "SCHIZOPHRENIA BULL",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Cross-sectional Study of Glutamate in the Anterior Cingulate and Hippocampus in Schizophrenia

AU - Gallinat, Jürgen

AU - McMahon, Kibby

AU - Kühn, Simone

AU - Schubert, Florian

AU - Schaefer, Martin

N1 - © The Author 2015. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

PY - 2016

Y1 - 2016

N2 - BACKGROUND: There has been growing support for dysfunctions of the excitatory glutamatergic system and its implications for the psychophysiology of schizophrenia. However, previous studies reported mixed results regarding glutamate concentrations in schizophrenia with varying deviations across brain regions.METHODS: We used an optimized proton magnetic resonance spectroscopy procedure to measure absolute glutamate concentrations in the left hippocampal region and the anterior cingulate cortex (ACC) in 29 medicated patients with schizophrenia and in 29 control participants without mental disorder.RESULTS: The glutamate concentrations were significantly lower in the ACC but higher in the hippocampus of patients compared to controls. ACC and hippocampal glutamate concentrations correlated positively in patients but not in controls. ACC glutamate was weakly associated with Clinical Global Impression score and duration of illness in patients.CONCLUSION: Glutamate concentrations in schizophrenia deviate from controls and show associations with disease severity. A higher concentration of hippocampal glutamate in schizophrenia compared to controls is shown. The association between ACC and hippocampus glutamate concentrations in patients with schizophrenia suggests an abnormal coupling of excitatory systems compared to controls as predicted by previous glutamate models of schizophrenia.

AB - BACKGROUND: There has been growing support for dysfunctions of the excitatory glutamatergic system and its implications for the psychophysiology of schizophrenia. However, previous studies reported mixed results regarding glutamate concentrations in schizophrenia with varying deviations across brain regions.METHODS: We used an optimized proton magnetic resonance spectroscopy procedure to measure absolute glutamate concentrations in the left hippocampal region and the anterior cingulate cortex (ACC) in 29 medicated patients with schizophrenia and in 29 control participants without mental disorder.RESULTS: The glutamate concentrations were significantly lower in the ACC but higher in the hippocampus of patients compared to controls. ACC and hippocampal glutamate concentrations correlated positively in patients but not in controls. ACC glutamate was weakly associated with Clinical Global Impression score and duration of illness in patients.CONCLUSION: Glutamate concentrations in schizophrenia deviate from controls and show associations with disease severity. A higher concentration of hippocampal glutamate in schizophrenia compared to controls is shown. The association between ACC and hippocampus glutamate concentrations in patients with schizophrenia suggests an abnormal coupling of excitatory systems compared to controls as predicted by previous glutamate models of schizophrenia.

U2 - 10.1093/schbul/sbv124

DO - 10.1093/schbul/sbv124

M3 - SCORING: Journal article

C2 - 26333842

VL - 42

SP - 425

EP - 433

JO - SCHIZOPHRENIA BULL

JF - SCHIZOPHRENIA BULL

SN - 0586-7614

IS - 2

ER -